A new therapy for systemic sclerosis-associated interstitial disease

被引：0
|
作者：
Kondoh, Yasuhiro [1 ]
机构：
[1] Nagoya Univ, Sch Med, Dept Resp Med & Allergy, Tosei Gen Hosp, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan
来源：
RESPIRATORY INVESTIGATION | 2020年 / 58卷 / 04期
关键词：
Cyclophosphamide; Nintedanib; Systemic sclerosis; Interstitial lung disease; Mycophenolate; LUNG-DISEASE; CYCLOPHOSPHAMIDE; DEATH;
D O I：
10.1016/j.resinv.2020.03.005
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：227 / 229
页数：3
相关论文
共 50 条
  • [21] Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease
    Silver, Richard M.
    Feghali-Bostwick, Carol A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 485 - 487
  • [22] Current treatment of systemic sclerosis-associated interstitial lung disease
    Bes, Cemal
    Cetinkaya, Erdogan
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (01): : 85 - 92
  • [23] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [24] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
    Rahaghi, Franck F.
    Hsu, Vivien M.
    Kaner, Robert J.
    Mayes, Maureen D.
    Rosas, Ivan O.
    Saggar, Rajan
    Steen, Virginia D.
    Strek, Mary E.
    Bernstein, Elana J.
    Bhatt, Nitin
    Castelino, Flavia V.
    Chung, Lorinda
    Domsic, Robyn T.
    Flaherty, Kevin R.
    Gupta, Nishant
    Kahaleh, Bashar
    Martinez, Fernando J.
    Morrow, Lee E.
    Moua, Teng
    Patel, Nina
    Shlobin, Oksana A.
    Southern, Brian D.
    Volkmann, Elizabeth R.
    Khanna, Dinesh
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [25] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    C. Meier
    K. Freiburghaus
    C. Bovet
    J. Schniering
    Y. Allanore
    O. Distler
    C. Nakas
    B. Maurer
    Scientific Reports, 10
  • [26] Characterization of the Pericyte Transcriptome in Systemic Sclerosis-associated Interstitial Lung Disease
    Wilson, C. L.
    Renaud, L.
    Simon, B.
    Feghali-Bostwick, C.
    Schnapp, L. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
    Franck F. Rahaghi
    Vivien M. Hsu
    Robert J. Kaner
    Maureen D. Mayes
    Ivan O. Rosas
    Rajan Saggar
    Virginia D. Steen
    Mary E. Strek
    Elana J. Bernstein
    Nitin Bhatt
    Flavia V. Castelino
    Lorinda Chung
    Robyn T. Domsic
    Kevin R. Flaherty
    Nishant Gupta
    Bashar Kahaleh
    Fernando J. Martinez
    Lee E. Morrow
    Teng Moua
    Nina Patel
    Oksana A. Shlobin
    Brian D. Southern
    Elizabeth R. Volkmann
    Dinesh Khanna
    Respiratory Research, 24
  • [28] Consensus statements for managing systemic sclerosis-associated interstitial lung disease
    Proudman, Susanna
    LANCET RHEUMATOLOGY, 2020, 2 (02): : E64 - E65
  • [29] evaluation of esophageal involvement in systemic sclerosis-associated interstitial lung disease
    Abida, Houssem
    Meddeb, Zeineb
    Abdelkefi, Cherifa
    El Ouni, Amira
    Toujani, Sana
    Hamzaoui, Saloua B'chir
    Larbi, Thara
    Bouslama, Kamel
    ACTA CLINICA BELGICA, 2023, 78 : 19 - 19
  • [30] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Allanore, Y.
    Distler, O.
    Nakas, C.
    Maurer, B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345